Yin, W.; Guo, M.; Tang, Z.; Toruner, G.A.; Cheng, J.; Medeiros, L.J.; Tang, G.
MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers 2022, 14, 2433.
https://doi.org/10.3390/cancers14102433
AMA Style
Yin W, Guo M, Tang Z, Toruner GA, Cheng J, Medeiros LJ, Tang G.
MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers. 2022; 14(10):2433.
https://doi.org/10.3390/cancers14102433
Chicago/Turabian Style
Yin, Wei, Ming Guo, Zhenya Tang, Gokce A. Toruner, Joanne Cheng, L. Jeffrey Medeiros, and Guilin Tang.
2022. "MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome" Cancers 14, no. 10: 2433.
https://doi.org/10.3390/cancers14102433
APA Style
Yin, W., Guo, M., Tang, Z., Toruner, G. A., Cheng, J., Medeiros, L. J., & Tang, G.
(2022). MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome. Cancers, 14(10), 2433.
https://doi.org/10.3390/cancers14102433